Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older
Zhang Wang,Xue Yang,Longxin Li,Xiaobo Zhang,Wenlin Zhou,Sixue Chen
DOI: https://doi.org/10.2147/cia.s454060
IF: 3.829
2024-03-20
Clinical Interventions in Aging
Abstract:Zhang Wang, 1 Xue Yang, 1 Longxin Li, 1 Xiaobo Zhang, 2 Wenlin Zhou, 1 Sixue Chen 1 1 Department of Geriatrics, The General Hospital of Western Theater Command, Chengdu, People's Republic of China; 2 The Third People's Hospital of Beichuan Qiang Autonomous County, Mianyang, People's Republic of China Correspondence: Zhang Wang, Department of Geriatrics, The General Hospital of Western Theater Command, No. 270 Rongdu Road, Chengdu, 610083, People's Republic of China, Tel +86-18981780413, Email Purpose: To evaluate the performance of the Framingham cardiovascular risk score (FRS)/pooled cohort equations (PCE)/China prediction for atherosclerotic cardiovascular disease (ASCVD) risk (China-PAR model) in a prospective cohort of Chinese older adults. Patients and Methods: We assessed 717 older adults aged 75– 85 years without ASCVD at the baseline from the Sichuan province of China. The participants were followed annually from 2011 to 2021. We obtained the participants' information through the medical records of physical examination and evaluated their 10-year ASCVD risk using FRS, PCE, and China-PAR. We further evaluated the predictive abilities of three assessment models. Results: During the 10-year follow-up, 206 participants developed ASCVD, with an incidence rate of 28.73%. The FRS and China-PAR moderately underestimated the risk of ASCVD (22.1% and 12.4%, respectively), but while PCE overestimated the risk (36.1%). FRS and China-PAR were found to underestimate the risk of ASCVD (26% and 63%, respectively) for men, while PCE overestimated the risk by 8%; For women, FRS and China-PAR were found to underestimate the risk of ASCVD (14% and 35%, respectively), while PCE overestimated the risk by 88%. Conclusion: The 10-year ASCVD risk was found to be overestimated by PCE. China-PAR had the most accurate predictions in women, while FRS was particularly well-calibrated in males. All three risk models have good discrimination, with FRS and PCE being well-calibrated in men and all three being well-calibrated in women. Therefore, accurate risk models are warranted to facilitate the prevention of ASCVD at the baseline among Chinese older adults. Keywords: ASCVD, risk prediction model, FRS, PCE, China-PAR Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality, similar to ischemic heart disease (IHD) and ischemic stroke, and it has been a major public health issue worldwide. 1 Blood lipid, smoking, and blood pressure are adjustable causal risk factors that may be rectified through lifestyle changes or drug use. 2 Risk prediction and stratification of ASCVD are efficient approaches toward preventive interventions for ASCVD. China has become an aging society, with an estimated peak approaching in 2053 at approximately 482 million population. 3 In China, the proportion of older persons (>65 years) has increased from 6.96% in 2000 to 13.50% in 2020, which is basically from the Fifth to the Seventh Population Census. 4 This demographic shift and the societal transformation in terms of lifestyle, environment, economy, and the health care system have largely contributed to the major CVD risk factors. 5 ASCVD is one of the main causes of mortality in older adults in China. 6 According to The American College of Cardiology (ACC) and the American Heart Association (AHA) guideline, individuals aged 40–75 years should be examined for CVD prevention as a part of a 10-year ASCVD risk assessment program. 7 So far, several models have been proposed for ASCVD risk evaluation and scientific guidance has been established in the domains of public health and clinical practice for different populations; for instance, Framingham general CVD equations in the United States 8 and the recent Pooled Cohort Equations (PCEs) for ASCVD. 9 Few evidence-based studies among older adults aged 75 years and above are available. 10 In 2016, the AHA/ACC/AGS also stated that the participants in most of the previous studies were adults aged less than 75 years. 11 According to the Outline of Healthy China 2030 Plan, the average life expectancy for Chinese people has significantly improved from 77 years in 2020 to 80 years in 2030. 4 Moreover, the older persons population has currently reached 19,060,000, accounting for 13.5% of the total population. The predictive performance of current prediction models for cardiovascular disease risk in elderly individuals is still unclear. However, there is still no ASCVD risk prediction model specifically for older adults (≥75 years). We utilized data based on Chinese hospitals, strategized this longitudinal rese -Abstract Truncated-
geriatrics & gerontology,gerontology